Neurocrine Biosciences, Inc [NASDAQ: NBIX] traded at a high on Tuesday, posting a 8.36 gain after which it closed the day’ session at $118.92.
The results of the trading session contributed to over 5008419 shares changing hands. Over the past one week, the price volatility of Neurocrine Biosciences, Inc stands at 4.53% while the volatility over the past one month is 4.84%.
The market cap for NBIX stock reached $11.77 billion, with 99.00 million shares outstanding and 96.08 million shares in the current float. Compared to the average trading volume of 1.61M shares, NBIX reached a trading volume of 5008419 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Neurocrine Biosciences, Inc [NBIX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NBIX shares is $160.58 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NBIX stock is a recommendation set at 1.37. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Needham have made an estimate for Neurocrine Biosciences, Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 15, 2025. The new note on the price target was released on April 14, 2025, representing the official price target for Neurocrine Biosciences, Inc stock. Previously, the target price had yet another raise to $138, while Deutsche Bank analysts kept a Hold rating on NBIX stock.
The Average True Range (ATR) for Neurocrine Biosciences, Inc is set at 5.14, with the Price to Sales ratio for NBIX stock in the period of the last 12 months amounting to 4.88. The Price to Book ratio for the last quarter was 4.64, with the Price to Cash per share for the same quarter was set at 9.54. Price to Free Cash Flow for NBIX in the course of the last twelve months was 23.90 with Quick ratio for the last quarter at 3.02.
How has NBIX stock performed recently?
Neurocrine Biosciences, Inc [NBIX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 10.89. With this latest performance, NBIX shares gained by 24.33% in over the last four-week period, additionally sinking by -1.12% over the last 6 months – not to mention a drop of -14.95% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NBIX stock in for the last two-week period is set at 70.20, with the RSI for the last a single of trading hit 81.05, and the three-weeks RSI is set at 62.55 for Neurocrine Biosciences, Inc [NBIX]. The present Moving Average for the last 50 days of trading for this stock 107.39, while it was recorded at 110.53 for the last single week of trading, and 124.87 for the last 200 days.
Neurocrine Biosciences, Inc [NBIX]: Deeper insight into the fundamentals
Neurocrine Biosciences, Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.02 and a Current Ratio set at 3.13.
Earnings analysis for Neurocrine Biosciences, Inc [NBIX]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for NBIX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Neurocrine Biosciences, Inc go to 34.79%.
Insider trade positions for Neurocrine Biosciences, Inc [NBIX]
The top three institutional holders of NBIX stocks are: BLACKROCK INC. with ownership of 14.19 million shares, which is approximately 14.0781%. VANGUARD GROUP INC, holding 10.06 million shares of the stock with an approximate value of $$1.38 billion in NBIX stocks shares; and VANGUARD GROUP INC, currently with $$634.43 million in NBIX stock with ownership which is approximately 4.5718%.
